Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma. A Phase II Multicenter Study "BENTLY".
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2016
At a glance
- Drugs Bendamustine (Primary)
- Indications Cutaneous T cell lymphoma; Peripheral T-cell lymphoma; T cell lymphoma
- Focus Therapeutic Use
- Acronyms BENTLY
- 08 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 22 Aug 2009 New trial record